Liquid Biopsy Sample Articles & Analysis
6 news found
About See.d See.d is the first universal blood sample preparator for liquid biopsy analysis, automating and standardizing preparation at the point of collection. ...
“Promega has demonstrated exceptional quality of results from samples processed with their proven reagents on Maxwell systems, which have been adopted globally for liquid biopsies. ...
SAGA Diagnostics AB is seeking a talented and highly motivated Bioinformatics Scientist with strong interest in advancing our mission to revolutionize cancer diagnostics through proprietary ultrasensitive technologies that measure circulating tumor DNA (ctDNA) in minimally-invasive “liquid biopsies” such as a simple blood sample. The ...
SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncology and non-invasive ultrasensitive monitoring of cancer patients, has entered into an assay development agreement with the global, science-led biopharmaceutical company AstraZeneca (LSE/STO/Nasdaq: AZN). SAGA Diagnostics will in the course of this agreement ...
Pierre Sonigo, Chief Scientific Officer of the Sebia Group, said "Metafora's technology achieves the equivalent of a PET-Scan, the reference technology for cancer imaging, on "liquid biopsies", i.e., from a simple blood sample. The resolution of this analysis, which is based on flow cytometry, is the highest achievable since the ...
SAGA Diagnostics AB (“SAGA”), a cancer liquid biopsy and genomic testing company, today announced that it has raised SEK 106 million (€10.5 million) in a Series A2 financing from both existing and new investors. ...